Please login to the form below

Not currently logged in

Dr Jay Stout moves from Merck to SanBio

He joins as senior vice president of manufacturing

California-based SanBio has appointed Dr Jay Stout as senior vice president of manufacturing.

In this role, he is responsible for all production-related operations, including clinical cell preparation, final quality assurance and process development.

Dr Stout said: “I'm eager to roll up my sleeves to prepare SanBio's promising cell therapies for scaled-up production and rapid rollout.

“The clinical results are exciting and brings a breakthrough technology to commercialisation is a challenge I've met several times before.”

He brings 25 years of biological development and commercialisation expertise to SanBio, having most recently served as executive director of Merck's Center for Biopharmaceutical Manufacturing.

Prior to this, Dr Stout was executive director of Amgen's Manufacturing Sciences and Technology group during which time he served as global process team lead of its blockbuster anti-TBF product, Enbrel.

Keita Mori, SanBio's chief executive officer, said: “We're delighted to welcome Jay on board.

“He is perhaps the individual with the greatest experience in the world in manufacturing scale-up of biologics similar to SB623 stem cell therapy.

“He fills our what is a genuinely world-class development and operations team.”

19th April 2016

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?